Bharat Biotech
-
Coronavirus: Mansukh Mandaviya launches India’s first intranasal vaccine
Scroll Staff
-
Covid-19: Bharat Biotech to launch intranasal vaccine on January 26
Scroll Staff
-
Covid-19: Bharat Biotech’s intranasal vaccine gets emergency use approval
Scroll Staff
-
Coronavirus: Bharat Biotech says its intranasal vaccine is safe, generates immune response
Scroll Staff
-
Bharat Biotech must address WHO suspension on procuring Covaxin through UN, says foreign ministry
Scroll Staff
-
WHO suspends Covaxin supply through United Nations agencies citing manufacturing deficiencies
Scroll Staff
-
The big news: Nawab Malik sent to ED custody till March 3, and nine other top stories
Scroll Staff
-
‘The Wire’ says Bharat Biotech did not serve notice before filing defamation case
Scroll Staff
-
The big news: Kerala reports more than 54,000 Covid cases, and nine other top stories
Scroll Staff
-
Bharat Biotech gets approval to conduct trials for its intranasal Covid-19 booster dose
Scroll Staff
-
Covaxin booster dose neutralises both Delta and Omicron variants, says Bharat Biotech
Scroll Staff
-
No proof of Covaxin’s efficacy against Omicron strain in Bharat Biotech’s study on booster dose
Scroll Staff
-
Covaxin has shown good immune response among children, says Covid panel chief
Scroll Staff
-
Covaxin receives DCGI approval for use in children from 12 to 18 years
Scroll Staff
-
Covaxin shows 50% efficacy against symptomatic cases of coronavirus: Lancet study
Scroll Staff
-
Covaxin is 77.8% effective in symptomatic cases, shows phase 3 trial data: Lancet study
Scroll Staff
-
Covid: UK to recognise Covaxin as an approved vaccine from November 22
Scroll Staff
-
Coronavirus: Bharat Biotech’s US partner seeks emergency approval to Covaxin for children
Scroll Staff
-
Coronavirus: Covaxin approved for emergency use by WHO
Scroll Staff
-
Covid: Australia recognises Covaxin for travel as it eases border restrictions
Scroll Staff